Elena Rainero

Dr. Elena Rainero

University of Sheffield, Sheffield, UK
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Cell Reports
Verified
Journal Article
Open access
Elena RaineroElena Rainero
Elena Rainero
JHJonathan D. Howe
Jonathan D. Howe
PCPatrick T. Caswell
Patrick T. Caswell
NJNigel B. Jamieson
Nigel B. Jamieson
KAKurt Anderson
Kurt Anderson
JNJim C. Norman
Jim C. Norman
Integrin trafficking is key to cell migration, but little is known about the spatiotemporal organization of integrin endocytosis. Here, we show that α5β1 integrin undergoes tensin-dependent centripetal movement from the cell periphery to populate adhesions located under the nucleus. From here, ligand-engaged α5β1 integrins are internalized under control of the Arf subfamily GTPase, Arf4, and are trafficked to nearby late endosomes/lysosomes. Suppression of centripetal movement or Arf4-dependent endocytosis disrupts flow of ligand-bound integrins to late endosomes/lysosomes and their degradation within this compartment. Arf4-dependent integrin internalization is required for proper lysosome positioning and for recruitment and activation of mTOR at this cellular subcompartment. Furthermore, nutrient depletion promotes subnuclear accumulation and endocytosis of ligand-engaged α5β1 integrins via inhibition of mTORC1. This two-way regulatory interaction between mTORC1 and integrin trafficking in combination with data describing a role for tensin in invasive cell migration indicate interesting links between nutrient signaling and metastasis.

23 January 2012 in Journal of Cell Biology
Verified
Journal Article
Open access
Elena RaineroElena Rainero
Elena Rainero
PCPatrick T. Caswell
Patrick T. Caswell
Patricia A. J. MullerPatricia A. J. Muller
Patricia A. J. Muller
JGJoan Grindlay
Joan Grindlay
MMMary W. McCaffrey
Mary W. McCaffrey
JNJim C. Norman
Jim C. Norman
Inhibition of αvβ3 integrin or expression of oncogenic mutants of p53 promote invasive cell migration by enhancing endosomal recycling of α5β1 integrin under control of the Rab11 effector Rab-coupling protein (RCP). In this paper, we show that diacylglycerol kinase α (DGK-α), which phosphorylates diacylglycerol to phosphatidic acid (PA), was required for RCP to be mobilized to and tethered at the tips of invasive pseudopods and to allow RCP-dependent α5β1 recycling and the resulting invasiveness of tumor cells. Expression of a constitutive-active mutant of DGK-α drove RCP-dependent invasion in the absence of mutant p53 expression or αvβ3 inhibition, and conversely, an RCP mutant lacking the PA-binding C2 domain was not capable of being tethered at pseudopod tips. These data demonstrate that generation of PA downstream of DGK-α is essential to connect expression of mutant p53s or inhibition of αvβ3 to RCP and for this Rab11 effector to drive the trafficking of α5β1 that is required for tumor cell invasion through three-dimensional matrices.

26 February 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
MNMona Nazemi
Mona Nazemi
Elena RaineroElena Rainero
Elena Rainero
The extracellular matrix (ECM) is a complex network of secreted proteins which provides support for tissues and organs. Additionally, the ECM controls a plethora of cell functions, including cell polarity, migration, proliferation, and oncogenic transformation. One of the hallmarks of cancer is altered cell metabolism, which is currently being exploited to develop anti-cancer therapies. Several pieces of evidence indicate that the tumor microenvironment and the ECM impinge on tumor cell metabolism. Therefore, it is essential to understand the contribution of the complex 3D microenvironment in controlling metabolic plasticity and responsiveness to therapies targeting cell metabolism. In this mini-review, we will describe how the tumor microenvironment and cancer-associated fibroblasts dictate cancer cell metabolism, resulting in increased tumor progression. Moreover, we will define the cross-talk between nutrient signaling and the trafficking of the ECM receptors of the integrin family. Finally, we will present recent data highlighting the contribution of nutrient scavenging from the microenvironment to support cancer cells growth under nutrient starvation conditions.

14 November 2012 in Cancer Research
Verified
Journal Article
Closed access
SRSabrina Rizzolio
Sabrina Rizzolio
NRNoa Rabinowicz
Noa Rabinowicz
Elena RaineroElena Rainero
Elena Rainero
LLLetizia Lanzetti
Letizia Lanzetti
Guido SeriniGuido Serini
Guido Serini
LTLuca Tamagnone
Luca Tamagnone
Neuropilin-1 (NRP1) is a coreceptor for multiple extracellular ligands. NRP1 is widely expressed in cancer cells and in advanced human tumors; however, its functional relevance and signaling mechanisms are unclear. Here, we show that NRP1 expression controls viability and proliferation of different cancer cells, independent of its short intracellular tail. We found that the extracellular domain of NRP1 interacts with the EGF receptor (EGFR) and promotes its signaling cascade elicited upon EGF or TGF-α stimulation. Upon NRP1 silencing, the ability of ligand-bound EGFR to cluster on the cell surface, internalize, and activate the downstream AKT pathway is severely impaired. EGFR is frequently activated in human tumors due to overexpression, mutation, or sustained autocrine/paracrine stimulation. Here we show that NRP1-blocking antibodies and NRP1 silencing can counteract ligand-induced EGFR activation in cancer cells. Thus our findings unveil a novel molecular mechanism by which NRP1 can control EGFR signaling and tumor growth. Cancer Res; 72(22); 5801–11. ©2012 AACR.

1 January 2014 in Journal of Cell Science
Verified
Journal Article
Closed access
IMIain R Macpherson
Iain R Macpherson
Elena RaineroElena Rainero
Elena Rainero
LMLouise E Mitchell
Louise E Mitchell
PBPeter Ve van Den Berghe
Peter Ve van Den Berghe
CSClaire Speirs
Claire Speirs
JNJim C Norman
Jim C Norman
Chloride intracellular channel 3 (CLIC3) drives invasiveness of pancreatic and ovarian cancer by acting in concert with Rab25 to regulate recycling of α5β1 from late endosomes to the plasma membrane. Here we show that in two estrogen receptor (ER)-negative breast cancer cell lines CLIC3 has little influence on integrin recycling, but controls trafficking of the pro-invasive matrix metalloprotease, MT1-MMP. In MDA-MB-231 cells MT1-MMP and CLIC3 are localised primarily to late endosomal/lysosomal compartments located above the plane of adhesion and near the nucleus. MT1-MMP is transferred from these late endosomes to sites of cell-matrix adhesion in a CLIC3-dependent fashion. Correspondingly, CLIC3-knockdown opposes MT1-MMP-dependent invasive processes. These include the disruption of the basement membrane as acini formed from MCF10DCIS.com cells acquire invasive characteristics in 3D culture, and the invasion of MDA-MB-231 cells into Matrigel or organotypic plugs of type I collagen. Consistent with this, expression of CLIC3 predicts poor prognosis in ER-negative breast cancer. The identification of MT1-MMP as a cargo of a CLIC3-regulated pathway that drives invasion highlights the importance of late endosomal sorting and trafficking in breast cancer.

21 December 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
Emmanuel DornierEmmanuel Dornier
Emmanuel Dornier
NRNicolas Rabas
Nicolas Rabas
LMLouise Mitchell
Louise Mitchell
DNDavid Novo
David Novo
SDSandeep Dhayade
Sandeep Dhayade
JNJim C. Norman
Jim C. Norman
The role of glutaminolysis in providing metabolites to support tumour growth is well-established, but the involvement of glutamine metabolism in invasive processes is yet to be elucidated. Here we show that normal mammary epithelial cells consume glutamine, but do not secrete glutamate. Indeed, low levels of extracellular glutamate are necessary to maintain epithelial homoeostasis, and provision of glutamate drives disruption of epithelial morphology and promotes key characteristics of the invasive phenotype such as lumen-filling and basement membrane disruption. By contrast, primary cultures of invasive breast cancer cells convert glutamine to glutamate which is released from the cell through the system Xc- antiporter to activate a metabotropic glutamate receptor. This contributes to the intrinsic aggressiveness of these cells by upregulating Rab27-dependent recycling of the transmembrane matrix metalloprotease, MT1-MMP to promote invasive behaviour leading to basement membrane disruption. These data indicate that acquisition of the ability to release glutamate is a key watershed in disease aggressiveness.